STEREOTAXIS, INC. (OTCMKTS:STXS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Number of Shares Entitled to Vote: |
73,779,522 |
Number of Votes For: |
54,674,109 |
Number of Votes Against: |
6,048,527 |
Number of Votes Abstain: |
179,390 |
Number of Broker Non-Votes: |
(5) | Proposal to approve an amendment to the Company’s certificate of incorporation to authorize a reduction of the authorized number of shares of our common stock from 300,000,000 to 100,000,000 shares: |
Number of Total Shares Entitled to Vote: |
73,779,522 |
Total Number of Votes For: |
48,261,003 |
Total Number of Votes Against: |
408,788 |
Total Number of Votes Abstain: |
26,324 |
Total Number of Broker Non-Votes: |
12,205,911 |
Number of Common Shares Entitled to Vote: |
58,865,036 |
Number of Common Votes For: |
40,384,815 |
Number of Common Votes Against: |
408,788 |
Number of Common Votes Abstain: |
26,324 |
Number of Common Broker Non-Votes: |
12,205,911 |
About STEREOTAXIS, INC. (OTCMKTS:STXS)
Stereotaxis, Inc. is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab. The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information. The Company’s Epoch solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The Niobe ES remote magnetic navigation system includes the Navigant software user interface and the QuikCAS catheter advancement system. The Vdrive robotic navigation system with Niobe ES magnetic navigation system provides navigation and stability for diagnostic and ablation devices.